The interleukin-17 pathway is involved in human alcoholic liver disease # †

Lemmers, Arnaud, Moreno, Christophe, Gustot, Thierry, Maréchal, Raphaël, Degré, Delphine, Demetter, Pieter, de Nadai, Patricia, Geerts, Albert +4 more·2009·Hepatology
DOI 10.1002/hep.22680

Cited by (394)

Items 301–394 of 394

  1. Epidemiology and Pathogenesis of Alcoholic Liver Disease
    Bin Gao, Samir Zakhari · 2018 · Elsevier eBooks
  2. Severe alcoholic hepatitis as precipitant for organ failure and ACLF
    J. Trebicka, A. Louvet, V. Arroyo, R. Jalan, V. Shah, R. Moreau · 2021 · Zeitschrift für Gastroenterologie - German Journal of Gastroenterology
  3. Clinical Trial to Assess the Safety and Tolerability of Anti‐ IL 23 Monoclonal Antibody Guselkumab in Patients With Alcohol‐Associated Liver Disease
    Luis Antonio Díaz, Sheldon Morris, Shravan Dave, Susy M. Kim, Wathnita Sarik, Lisa Richards, Egbert V. Madamba, Ricki Bettencourt, Christian Fulinara, Thuy Thi Thanh Pham et al. · 2025 · Alimentary Pharmacology & Therapeutics
  4. Non-immune functions of inflammatory cytokines targeted by anti-psoriatic biologics: a review
    Tung-Lin Lee, Tsen‐Fang Tsai · 2022 · Inflammation Research
  5. Quantitative Estimation of Interleukin-17 in Patients with Chronic Liver Disorders
    Ghazy Na, Hadir Ahmed Said Okasha, El Khouly Eh, SM Abdelsalam, Morsi Mg · 2012 · Journal of Ecosystem & Ecography
  6. Hepatic Safety of IL-17 Inhibitors in Psoriasis and Psoriatic Arthritis: A 12-Month Retrospective Cohort Evaluation Using the FIB-4 Index
    Umut Bakay, Tuğba İzci Duran, Özge Sevil Karstarlı Bakay, Rahime Ekmekçioğlu · 2026 · Dermatology Practical & Conceptual
  7. Inflammation and Liver Injury
    Pranoti Mandrekar, Gyöngyi Szabó · 2010 · Molecular pathology library
  8. Cellular Signaling Pathways in Alcoholic Liver Disease
    Pranoti Mandrekar, Aditya Ambade · 2012 · InTech eBooks
  9. Immune and Inflammatory Pathways in Non-Alcoholic Steatohepatitis (NASH). An update
    Sorina Cezara Coste, Ionela Popovici, Andreea Stefan, Iulia Breaban, Adela Viviana Sitar Tǎut, Simina Țărmure, Angela Cozma, Dorel Sâmpelean, Olga Hilda Orasan, Vasile Negrean et al. · 2019 · Journal of Mind and Medical Sciences
  10. Regulation of Liver Fibrosis during Murine Schistosomiasis Mansoni
    Tarek K. Zaalouk, Gamal A. Abo-Sheishaa, Ibrahim R Shalash · 2020 · The Egyptian Journal of Hospital Medicine
  11. Desregulación inmunológica y fisiopatología del consumo de alcohol y la enfermedad hepática alcohólica
    Moisés Martínez‐Castillo, Itzel Altamirano-Mendoza, S. Sánchez-Valle, L. García-Islas, M. Sánchez-Barragán, Marisela Hernandez-Santillan, Abigail Hernández-Barragán, José Luis Pérez-Hernández, Fatima Higuera‐de la Tijera, Gabriela Gutiérrez‐Reyes · 2023 · Revista de Gastroenterología de México
  12. Value of inflammatory response and oxidative damage in the diagnosis of infections in severe alcoholic hepatitis
    Onán Pérez‐Hernández, Emilio González‐Reimers, Alen García Rodríguez, Camino María Fernández-Rodríguez, Pedro Abreu-González, J.M. González-Pérez, María José Sánchez-Pérez, Iván Ferraz‐Amaro, Candelaria Martín‐González · 2023 · European Journal of Internal Medicine
  13. Small-molecule chemical probes for the potential therapeutic targets in alcoholic liver diseases
    Ashish Dogra, Feng Li · 2023 · Liver Research
  14. Circulating cytokines and alcoholic liver disease: a two-sample bidirectional Mendelian randomization study
    Duan Wu, Ouyang Hao, Weiye Hu, Zhaorong Wu, Linke Bian, Hongye Wang, Junfeng Zhu · 2023 · Scandinavian Journal of Gastroenterology
  15. Neutrophil and macrophage crosstalk might be a potential target for liver regeneration
    Yiyuan Chen, Yijie Yang, Jinjiao Lu, Huan Chen, Zhixiong Shi, Xiaodong Wang, Nan Xu, Xiao Xu, Shuai Wang · 2024 · FEBS Open Bio
  16. Hepatic Fibrosis in Hepatitis C
    Melissa A. Sheiko, Hugo R. Rosen · 2016 · Springer eBooks
  17. Stellate Cells in Alcoholic Hepatitis
    Palash Mandal, Laura E. Nagy · 2015 · Elsevier eBooks
  18. Factors Influencing Liver Abnormalities in Psoriatic Arthritis Patients: A Comprehensive Study
    Ping Seung Ong, Lay Kim Tan, Hasnah Mat, Najjah Tohar, Abdul Muhaimin Fathi, Nia Maslia Atiera Kosenin, Muhammad N. Naim, Rafiqah Farhanah Redzuan, Nur Iffah Ab Rani, Najiha Arrissa Norhisham et al. · 2024 · Mediterranean Journal of Rheumatology
  19. Prior Trichinella spiralis infection protects against Schistosoma mansoni induced hepatic fibrosis
    Asmaa M. El-Kady, Sarah Abdulaziz Altwaim, Majed Hamdi Wakid, Alaa S. Banjar, Khalil Mohammed, Mashael Saleh Alfaifi, Hayam Elshazly, Wafa Abdullah I. Al‐Megrin, Eman Alshehri, Eman Sayed et al. · 2024 · Frontiers in Veterinary Science
  20. The interaction between IL-17 and gut microbiota contributes to cholestatic liver disease in children
    Shuli He, Zhuoheng Li, Juan Li, Ying Li · 2025 · Microbiology
  21. Role of Neutrophils in the Development of Steatotic Liver Disease
    You‐Jin Choi, Yeon Soo Kim, Seonghwan Hwang · 2024 · Seminars in Liver Disease
  22. Alcoholic Liver Disease
    Gyöngyi Szabó · 2013 · Springer eBooks
  23. Preoperative Interleukin-22 Values Add Valuable Information for Outcome Prediction Following Orthotopic Liver Transplantation: A Preliminary Study
    Bertram Scheller · 2014 · Annals of Transplantation
  24. The Immunopathogenesis of Cirrhosis
    Bin Gao, Scott L. Friedman, Wajahat Zafar Mehal · 2013 · Springer eBooks
  25. Evaluation of serum fibrotic markers; CTGF, IL-17and TGF-β1 versus liver biopsy for detection of hepatic fibrosis in Egyptian patients with chronic hepatitis C
    Samar Kamal Kassim, Sanaa Moharram Kamal, Hanan Hussien Shehata, M.M. Salib, Manal Louis Louka, Maha Mohamed Sallam, Lila Nabegh · 2017 · Meta Gene
  26. Alcoholic and Non-Alcoholic Fatty Liver Diseases
    Gary C. Kanel, Jacob Korula · 2011 · Elsevier eBooks
  27. Oxidative stress in alcohol-related liver disease
    Huey Kuan Tan, Euan Yates, Kristen Lilly, Ashwin Dhanda · 2020 · World Journal of Hepatology
  28. Assessment of immune function and prediction of survival and infection in patients with severe alcoholic hepatitis: An exploratory study
    Paula Boeira, Huey Kuan Tan, Euan Yates, Ashwin Dhanda · 2023 · JGH Open
  29. Activation of stem cell up-regulation/mobilization: a cardiovascular risk in both mice and humans with implications for liver disease, psoriasis and SLE
    John M. Gemery, Andrew R. Forauer, Eric K. Hoffer · 2019 · Vascular Health and Risk Management
  30. Changes in CD4+ T cells subsets in patients with alcohol-related cirrhosis
    Paola Zuluaga, Coral Zurera-Egea, Daniel Fuster, Anna Hernández‐Rubio, Aina Teniente‐Serra, Eva María Martínez-Cáceres, Roberto Muga · 2025 · Clinical and Experimental Medicine
  31. IL-17A-induced NETs are profibrogenic in mice with metabolic dysfunction-associated steatotic liver disease (MASLD)
    Mohamed N. Abdelnabi, Yousef Maali, Afrooz Dabbaghizadeh, Niloufar Mokariasl, Jessica Dion, Raya Yamak, Geneviève Soucy, Ghada S Hassan, Naglaa H. Shoukry · 2026 · The Journal of Immunology
  32. Effets hépatiques de l’alcool
    Fatima Teixeira-Clerc · 2015 · Cahiers de Nutrition et de Diététique
  33. The role of the reduction of extracellular calcium ion concentrations in activation of human peripheral blood T cells
    I. S. Litvinov, Irina Mersiyanova · 2015 · Russian Journal of Bioorganic Chemistry
  34. Role of Th17 and Treg during the Chronic Infection of Hepatitis C Virus
    Hyun Mu Shin, Jaewon Lee, Nam‐Hyuk Cho · 2015 · Journal of Bacteriology and Virology
  35. Immunopathology of the Hepatobiliary System
    Danielle L. Brown · 2017 · Molecular and integrative toxicology
  36. Alcoholic Liver Disease
    Stephen F. Stewart, Chris Day · 2012 · Elsevier eBooks
  37. Immunopathogenesis of Liver Cirrhosis
    Adrien Guillot, Bin Gao · 2020 · Springer eBooks
  38. Atención odontológica en pacientes con cirrosis hepática, una praxis que necesita ser considerada
    Ingrid Viridiana Hernández González, Moisés Martínez‐Castillo, Gabriela Gutiérrez‐Reyes, Lía Hoz · 2023 · HOLOPRAXIS Revista de Ciencia Tecnología e Innovación
  39. The Regulation of Bone Metabolism by the Liver
    Jing Luo, Yingting Zhang, Yinkun Fu, Yongjiao Huang, Zhihui Zou, Longchuan Han · 2024 · Nature Cell and Science
  40. The Role of the Acute-Phase Proteins in the Development and Progression of Liver Diseases
    Mendez Sanchez, Kobashi Margain Ramon Arturo, Gavilanes Espinar, Gutierrez Grobe, Ángel Armando Gutiérrez Jiménez, Uribe Misael · 2011 · InTech eBooks
  41. Impact of Cytokines in Hepatocellular Carcinoma Initiation and Progression
    Yeni Ait Ahmed, Fouad Lafdil · 2017 · Springer eBooks
  42. The Liver as an Immune Organ
    Gyöngyi Szabó, Banishree Saha, Aditya Ambade · 2018 · Elsevier eBooks
  43. Alcohol-Associated Liver Disease
    Mengfei Liu, Tejasav S. Sehrawat, G. Szabo, V. Shah · 2020 · Liver Immunology
  44. Mechanisms of Proinflammatory Signaling during Cholestasis
    Katryn Miller Allen · 2011
  45. Interleukin-17–targeted treatment of alcoholic liver disease #
    Enzo Emanuele, Marco Bertona · 2009 · Hepatology
  46. Authors' response
    Carl G. A. Persson, Lena Uller · 2011 · Thorax
  47. El patrón de producción de citocinas proinflamatorias en el líquido ascítico de pacientes con cirrosis está relacionado con la etiología viral (VHC) o alcohólica
    Ana Tapia‐Abellán, María Martínez Esparza, Antonio J. Ruiz‐Alcaraz, María Dolores Fernández, Juan F. Rodríguez-Alcázar, Cristina Martínez Pascual, Gonzalo Antón, Manuel Miras López, Pilar García–Peñarrubia · 2013
  48. Contribuição do componente C5 do sistema complemento em modelo experimental murino de doença hepática alcoólica.
    Lorena Bavia · 2013
  49. Alkohol, Leber, systemische Entzündung und Haut: Psoriasispatienten im Fokus
    Árpád Farkas, Lajos Vince Kemény · 2014 · Kompass Dermatologie
  50. Should we try antiviral therapy for hepatitis C virus infection with pyoderma gangrenosum‐like lesions?
    Kiminori Kimura · 2014 · Hepatology Research
  51. The Impact of Serum Interleukin-17 on Chronic Hepatitis C and Its
    SequelaeAhmed Hassan, Abeer Sharaf, Abd El-Rehim, Asmaa Omar Ahmed, Nahla M. Elsherbiny, Noha Abd El‐Rehim Abo Elhagag, Elham Ahmed Hassan · 2014
  52. Serum levels of interleukin 17 and its activators in chronic hepatitis C patients
    Krzysztof Gutkowski, Marek Hartleb, Teresa Kacperek‐Hartleb, Joanna A Musialik, Grzegorz Boryczka, Maciej Kajor · 2013
  53. Authors' response
    Monica Facco, Anna Cabrelle, Carlo Agostini · 2011 · Thorax
  54. Caracterização imunoistoquímica da população linfocitária septal e perisseptal na cirrose secundária à hepatopatia alcoólica
    Carlos Thadeu Schmidt Cerski · 2009 · Americanae (AECID Library)
  55. Clinical immunology Serum levels of interleukin 17 and its activators in chronic hepatitis C patients
    Krzysztof Gutkowski, Marek Hartleb, Teresa Kacperek‐Hartleb, Joanna A Musialik, Grzegorz Boryczka, Maciej Kajor · 2013 · Central European Journal of Immunology
  56. Relationship of circulating Th17/Treg ratio with hepatitis B e-antigen loss in chronic HBV infection patients receiving enticarvir(ETV) antiviral treatment
    Chun-hui SONG, Bin Yang, Liming Chen, Jiyuan Zhang · 2011 · Academic Journal of Second Military Medical University
  57. Exploration of Cytokine Signaling in Clinical Management of Hepatocellular Carcinoma
    Xuelian Zhao, Xin Wei Wang · 2012 · WORLD SCIENTIFIC eBooks
  58. Cytokines in Alcoholics
    Emilio González‐Reimers, Francisco J. Santolaria-Fernández · 2011 · Science Publishers eBooks
  59. Acute HCV in HIV positive men; viral evolution and cellular immune responses
    Emma C. Thomson · 2011 · Spiral (Imperial College London)
  60. HCV, Alcohol, and the Liver
    Terence Ndonyi Bukong, Banishree Saha, Gyöngyi Szabó · 2016 · Springer eBooks
  61. Involvement of Th17 Pathway in Adverse Drug Reactions: Mechanistic Investigation of Drug-induced Autoimmunity and Drug-induced Liver Injury
    Xu Zhu · 2013 · TSpace (University of Toronto)
  62. Relative and combined Effects of Ethanol and Hepatitis C Virus Infection on Serum Interleukin-17 Levels
    Emilio González‐Reimers, C Martín-González, Geraldine Quintero‐Platt, Lucía Romero-Acevedo, Onán Pérez‐Hernández · 2017 · Archives of Hepatitis Research
  63. WITHDRAWN: Cytokines and fatty liver diseases
    Lukas Niederreiter, Herbert Tilg · 2018 · Liver Research · Retracted
  64. Cutting-edge topics in the pathophysiology of alcoholic liver disease
    Kenichi Ikejima · 2018 · Kanzo
  65. Monocyte dysfunction in alcoholic hepatitis
    Nikhil Vergis · 2015
  66. Liver Cirrhosis with Steatohepatitis: Nonalcoholic Steatohepatitis and Alcoholic Steatohepatitis
    Teruki Miyake, Yoichi Hiasa · 2019 · Springer eBooks
  67. Interleukin 17 levels used as diagnostic marker for following up hepatitis C virus treatment
    Bayoumy B. E, Atta A.H., Keshta. AT, Kifafy. M.A · 2015 · Biochemistry Letters
  68. Alkoholische Lebererkrankungen (ALD)
    Carolin Lackner · 2020 · Pathologie
  69. A Simple Scoring Model Predicting the Outcome of COVID-19 Patients: Tanta COVID Score
    Mohammed Elhendawy, Ferial El-Kalla, Sherief Mohamed Abd-Elsalam, Dalia Ezzat Elsharawy, Shaimaa Soliman, Dina Abdelhai, Maha Mahmoud Hagras, Mai Ahmed Khalaf, Eslam Saber Esmail, Abdelrahman Abdelraouf Kobtan · 2021 · Endocrine Metabolic & Immune Disorders - Drug Targets
  70. Acute and Chronic Hepatitis B Virus Infection, Immune Response
    Mala K. Maini, Abhishek Das, Anna Schurich · 2014 · Springer eBooks
  71. Alcoholic Liver Disease
    José Altamirano, Eric S. Orman, Ramon A. Bataller · 2015 · Yamada's Textbook of Gastroenterology
  72. Histone deacetylases in alcohol associated Liver disease.
    Srineil Bodduluri · 2021
  73. ALCOHOLIC AND NON-ALCOHOLIC FATTY LIVER DISEASES
    Gary C. Kanel · 2023 · Elsevier eBooks
  74. Screening of common key immune genes and prediction of potential drugs in chronic hepatic injury
    Ting Pang, Jing Fu, Junxuan Li, Yong Chen, Huan He, Jiabao Ma, Liang Cao, Qiulian Tang, Naiqiang Hu, Meirong Zhao et al. · 2024 · Research Square
  75. Role of Kupffer cells and other immune cells
    Tobias Puengel, Frank Tacke · 2024 · Elsevier eBooks
  76. Alcohol-Induced Cell Injury
    Selver Ozsener Ozekinci · 2024
  77. Dietary salt intake worsens the Th17-dependent inflammatory profile of patients with cirrhosis
    Amalia Tzoumpa, Beatriz Lozano‐Ruiz, Yin Huang, Joanna Picó, Alba Moratalla, María Teresa Pomares, Iván Herrera, Juan José Lozano, María Rodríguez, Cayetano Miralles et al. · 2025 · JCI Insight
  78. Τα επίπεδα της ρετινόλης και των μεταβολιτών της σε ασθενείς με χρόνιες παθήσεις του ήπατος
    Αντίγονος Γιαγκούδης · 2013
  79. Hepatic Safety of IL-17 Inhibitors in Psoriasis and Psoriatic Arthritis: A 12-Month Retrospective Cohort Evaluation Using the FIB-4 Index
    Umut Bakay, Tuğba İzci Duran, Özge Sevil Karstarlı Bakay, Rahime Ekmekçioğlu · 2025 · Dermatology Practical & Conceptual
  80. Aescin and rutin mitigate hyperthyroidism-induced multisystem dysfunction via antioxidant and anti-inflammatory mechanisms in a rat model
    Minnatullah Makadi, Ibrahim Ibrahim, Hoda Ibrahim Bahr, Amr Elkelish, Oumarou Zongo, Hassan Rudayni, Amal A.M. Ahmed, Yasmina K. Mahmoud · 2026 · Scientific Reports
  81. Influence de la réponse IL-17 dans la physiopathologie du foie
    Adrien Guillot · 2014
  82. L’autophagie macrophagique protège contre l'atteinte hépatique et la fibrose au cours de la maladie alcoolique du foie
    Jasper Lodder · 2014 · theses.fr (ABES)
  83. Impact de l’interleukine-17 sur les cellules progénitrices intra-hépatiques au cours de la régénération et dans l’initiation tumorale du foie
    Imène Gasmi · 2018
  84. Étude du lien entre maladie alcoolique du foie, microbiote intestinal et acides biliaires : rôles spécifiques de la pectine et du récepteur aux acides biliaires TGR5
    Madeleine Spatz · 2018
  85. IL - 17 et réponse inflammatoire systémique : focus sur le foie et le muscle
    Audrey Beringer · 2018 · theses.fr (ABES)
  86. Liver pathophysiology at the single cell level : characterization of cellular heterogeneity and identification of novel therapeutic targets for chronic liver diseases and hepatocellular carcinoma
    Antonio Saviano · 2019 · theses.fr (ABES)
  87. The functional role of Claudin-1 as a mediator and therapeutic target in liver fibrogenesis and hepatocarcinogenesis
    Natascha Roehlen · 2021 · theses.fr (ABES)
  88. Caractérisation de la fibrose dans l'hépatite alcoolique et décryptage des mécanismes liant cette fibrose au défaut du compartiment hépatocytaire
    Line Carolle Ntandja Wandji · 2024
  89. Serum CC-Chemokine Profiling in Alcohol-Associated Liver Disease: Focus on MIP-3α/CCL20 as a Biomarker of Disease Severity
    A. Szczerbińska, Jacek Roliński, Agata Surdacka, H. Cichoż-Lach · 2026 · Diagnostics
  90. Neutrophils in Alcohol-Associated Hepatitis: Recruitment, Intrahepatic Amplification, and Pathogenic Functions
    Chao Lei · 2026 · Hepatobiliary Communications
  91. Mucosal‐Associated Invariant T Cells in Health and Disease
    Yu Zhao, Feng‐Mi Ou, Dan Liang, Yang Gao, Qing‐Qing Li, Yi‐Qun Kuang · 2026 · MedComm
  92. Clinical Implications of Interleukin-17 as a Hepato-Dermal Link in Patients With Psoriasis and Concomitant Steatotic Liver Disease
    Elaine C. Dupuis, Patrick Fleming, Rami Abou Zeinab, Bridgette Hartley, Maxime Barakat, Parbeer Singh Grewal · 2026 · Journal of Cutaneous Medicine and Surgery
  93. Étude in vitro de l’implication des cytokines de type Th17 dans la fibrose hépatique
    Thomas Fabre · 2013
  94. Alcohol and the Inflammatory Function of Immune Cells in Cancer Development
    H. Joe Wang · 2011 · Springer eBooks